Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
30/09/202214h00Business WireTeva Reaches Agreement With Georgia to Settle the State’s Price Fixing ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
26/09/202214h00Business WireTeva Launches Honestly HD Website to Provide People Living With Huntington’s Disease (HD) Information, Inspiration and Resources on HD ChoreaNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202221h58Business WireDes études démontrent l'efficacité d'AJOVY®▼ (frémanézumab) dans le traitement de la migraine chez des patients présentant une dépression comorbideNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202220h29Business WireStudien zeigen Wirksamkeit von AJOVY®▼ (Fremanezumab) bei der Behandlung von Migräne bei Patientinnen und Patienten mit komorbider DepressionNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202207h45Business WireStudies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid DepressionNYSE:TEVATeva Pharmaceutical Industries Ltd
07/09/202214h00Business WireCONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder and Digihaler System to Help Improve Asthma ManagementNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202218h26Business WireLa Commission européenne accorde une autorisation de mise sur le marché à Ranivisio▼®* (ranibizumab), un biosimilaire du Lucentis®**, pour le traitement de la dégénérescence maculaire liée à l'âge (DMLA), cause la plus fréquente de cécité dNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202217h56Business WireEuropäische Kommission erteilt Marktzulassung für Ranivisio▼®* (Ranibizumab), ein Biosimilar von Lucentis®** zur Behandlung von altersbedingter Makuladegeneration (AMD), der häufigsten Ursache für Erblindung in IndustrieländernNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202214h00Business WireTeva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022NYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202208h00Business WireEuropean Commission grants marketing authorization for Ranivisio▼®* (ranibizumab), a biosimilar to Lucentis®**, for age-related macular degeneration (AMD) the most common cause of blindness in developed countriesNYSE:TEVATeva Pharmaceutical Industries Ltd
24/08/202213h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/202213h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/202214h36TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Teva Pharmaceutical (TEVA), HUTCHMED (HCM) and Arcutis Biotherapeutics (ARQT)NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/202214h21TipRanksJ.P. Morgan Maintains Their Hold Rating on Teva Pharmaceutical (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202222h07Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202216h21TipRanksHere’s Why Teva Shares are Trending Higher TodayNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202213h31TipRanksThese Stocks Are the Biggest Pre-Market Movers on WednesdayNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202223h53Dow Jones NewsTeva Pharma ADRs Jump 17% On Pending Nationwide Agreement Over Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202222h55Business WireTeva Reports Second Quarter 2022 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/07/202214h00GlobeNewswire Inc.Certara Appoints Rosemary Crane as New Independent Board MemberNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/202215h53PR Newswire (US)Teva Pharmaceuticals accredited Migraine Friendly Workplace StampNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202223h05Dow Jones NewsADRs End Lower; Teva Pharmaceutical, Banco Santander Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202218h39Dow Jones NewsTeva Pharmaceutical, Abbvie's Allergan Settle Opioid Suit With San Francisco -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202217h38Dow Jones NewsTeva Pharmaceutical, Abbvie's Allergan Settle Opioid Suit With San FranciscoNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202216h30Business WireTeva Reaches Agreement With San Francisco to Settle Opioid-Related ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/202217h11Dow Jones NewsNew York Attorney General Seeks to Bring Teva Back Into Opioid Case -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/202216h31Dow Jones NewsNew York Attorney General Seeks to Bring Teva Back Into Opioid CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
05/07/202214h56Dow Jones NewsAgilent: FDA Approves Teva's Content Uniformity Method Using TRS100 SystemNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/202214h34Business WireTeva Announces Appointment of New Global R&D and Chief Medical OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
29/06/202222h09Business WireTeva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

Delayed Upgrade Clock